NORTH WEST STRATEGIC HEALTH AUTHORITY
FOURTH FLOOR, 3 PICCADILY PLACE, MANCHESTER, GREATER MANCHESTER, M1 3BN See member list for this organisation
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 14765 | 17816 | 82.9% | |
| HF 4 | 2011 | 15170 | 18385 | 82.5% | |
| HF 4 | 2012 | 17520 | 20891 | 83.9% |
